
Novo Nordisk A/S NVO
€ 38.80
1.58%
Novo Nordisk A/S DIO | NVO
DIO Jährlich Novo Nordisk A/S
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 338 | 318 | 305 | 288 | 285 | 247 | 259 | 273 |
Alle Zahlen in DKK-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 338 | 247 | 289 |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Фармсинтез
LIFE
|
120 | - | - | - | ||
|
Rhythm Pharmaceuticals
RYTM
|
417 | $ 101.8 | 0.08 % | $ 6.62 B | ||
|
Seer
SEER
|
343 | $ 1.95 | 0.26 % | $ 108 M | ||
|
Precigen
PGEN
|
95.7 | $ 6.87 | 0.14 % | $ 2.15 B | ||
|
SIGA Technologies
SIGA
|
606 | $ 3.2 | 1.86 % | $ 229 M | ||
|
Sarepta Therapeutics
SRPT
|
11.9 K | $ 20.94 | 0.04 % | $ 2.1 B | ||
|
Supernus Pharmaceuticals
SUPN
|
408 | $ 42.43 | 0.23 % | $ 2.4 B | ||
|
China SXT Pharmaceuticals
SXTC
|
329 | $ 2.24 | 0.45 % | $ 1.52 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
254 | $ 18.32 | 1.49 % | $ 28.9 B | ||
|
Bio-Techne Corporation
TECH
|
169 | $ 72.31 | 0.01 % | $ 11.3 B | ||
|
Tenax Therapeutics
TENX
|
840 | $ 1.98 | 2.06 % | $ 77.7 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
136 | $ 36.76 | 1.21 % | $ 42.1 B | ||
|
TG Therapeutics
TGTX
|
428 | $ 55.74 | 0.58 % | $ 8.04 B | ||
|
UroGen Pharma Ltd.
URGN
|
377 | $ 43.82 | 0.02 % | $ 2.11 B | ||
|
United Therapeutics Corporation
UTHR
|
162 | $ 497.97 | 2.12 % | $ 22.1 B | ||
|
Verrica Pharmaceuticals
VRCA
|
245 | $ 5.26 | 0.75 % | $ 56 M | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
320 | $ 528.9 | 0.22 % | $ 135 B | ||
|
Verastem
VSTM
|
403 | $ 8.08 | 0.55 % | $ 560 M | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
231 | $ 13.16 | 0.15 % | $ 112 M | ||
|
Xeris Pharmaceuticals
XERS
|
501 | $ 8.48 | 0.12 % | $ 1.36 B |